As the enforced PCHGB7 expression in those cells resulted in the induction of caspase-dependent apoptosis and sensitization to carboplatin [225], this finding delineates PCHGB7 as a potential tool for targeting GRP75 in breast tumors. This evidence concerns the gene HSPA9 and breast neoplasm.